Treatment

Jyseleca 200 mg film-coated tablets clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic use (Phase IV)
The effect of Janus Kinase inhibitors on the heart in Rheumatoid Arthrtis
This study looks at how a medicine called Jyseleca (filgotinib) affects the heart in people with Rheumatoid Arthritis (RA) who haven't had heart problems before. Researchers will check heart function before and after one year of treatment to see if the medicine changes it.
For: Diagnosis of RA according to the ACR/EULAR 2010 criteria without a history of cardiovascular diseases, Rheumatroid Arthritis
Netherlands